HAYW Form 4: CEO Holleran Exercises Options and Sells 60,571 Shares
Hayward Holdings, Inc. (HAYW) Form 4 summary: Kevin Holleran, listed as President, CEO and a director, reported transactions dated 09/03/2025.
Rhea-AI Filing Summary
Hayward Holdings, Inc. (HAYW) Form 4 summary: Kevin Holleran, listed as President, CEO and a director, reported transactions dated 09/03/2025. He exercised stock options to acquire 60,571 shares at an exercise price of $1.40 per share and simultaneously reported the acquisition of 60,571 shares. He also sold 60,571 shares in multiple transactions at a weighted average price of $15.7183 per share (range $15.59 to $15.8050). Following these transactions, the Form reports 2,696,284 shares beneficially owned with derivative holdings and 623,540 shares directly beneficially owned after the sale; three blocks of 700 shares are reported as indirectly owned by each of three children.
Positive
- Option exercise executed at $1.40, converting vested derivative rights into common shares
- Substantial retained stake: filing discloses 2,696,284 shares beneficially owned including derivatives
Negative
- Insider sale of 60,571 shares on 09/03/2025 at a weighted average price of $15.7183 may indicate partial monetization
- Sale executed in multiple transactions across a price range ($15.59 to $15.8050), requiring further breakdown for precise trade-level analysis
Insights
TL;DR: Insider exercised options, sold the same number of shares acquired, and retains substantial beneficial ownership.
Kevin Holleran exercised 60,571 options at $1.40 and sold 60,571 shares at a weighted average of $15.7183 on 09/03/2025. The filing discloses a remaining total beneficial position of 2,696,284 shares when including derivative holdings and direct ownership of 623,540 shares after the sale. The sale price range was disclosed as $15.59 to $15.8050 and the reporting person offers to provide breakdowns of quantities sold at each price upon request. These are routine Section 16 transactions showing option exercise liquidity and partial monetization without any additional disclosures of plans or changes in role.
TL;DR: Transactions appear documented and comply with Form 4 reporting; no new governance events disclosed.
The filing is signed by an attorney-in-fact and includes the 10b5-1 plan checkbox indicating the transaction was made pursuant to a written plan. The Form shows both acquisition via option exercise and contemporaneous open-market sales of the same share count. The filing does not state any change in officer or director status and provides an explanation that sales occurred across a price range. No material corporate governance actions or departures are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 60,571 | $0.00 | $0.00 |
| Exercise | Common Stock | 60,571 | $1.40 | $85K |
| Sale | Common Stock | 60,571 | $15.7183 | $952K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $15.59 to $15.8050, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kevin Holleran report on the HAYW Form 4 filed for 09/03/2025?
Were the sales executed under a trading plan for HAYW insider transactions?
Who signed the Form 4 filing for Kevin Holleran?
AI-generated analysis. How Rhea-AI works. Not financial advice.
